Skip to content

Prospective randomized controlled study on the treatment of metabolic syndrome with Fuyang Yunshu method

Prospective randomized controlled study on the treatment of metabolic syndrome with Fuyang Yunshu method

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041963
Enrollment
Unknown
Registered
2021-01-10
Start date
2021-01-10
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Sponsors

Guangdong Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The diagnostic criteria of metabolic syndrome were met; 2. The age ranged from 18 to 75 years old; 3. They are willing to obey the doctor's treatment plan and cooperate with the follow-up, and sign the informed consent form; 4. According to abdominal obesity: waist circumference >= 90cm in male and 85CM in female; or BIM >= 25kg / m2; 5. Patients with spleen and kidney yang deficiency, dampness and blood stasis syndrome; 6. Blood glucose, blood pressure, blood lipid and other medical treatment program stable for more than 2 months.

Exclusion criteria

Exclusion criteria: 1. Severe cardiac, hepatic and renal insufficiency (serum creatinine clearance rate = 2.5 times normal upper limit, total bilirubin >= 1.5 times normal upper limit; chronic heart failure, cardiac function grade III and above); 2. Malignant tumor patients; 3. Patients with cardiovascular and cerebrovascular diseases in recent half a year; 4. Patients with acute infection; 5. Pregnant or lactating women; 6. Patients with mental illness can not understand the nature, scope and possible results of the study or fail to comply with medical advice; 7. Those who are participating in other similar interventions; 8. Secondary dyslipidemia, blood pressure and blood glucose were found; 9. Type 1 diabetes mellitus; 10. Patients with vitiligo, or allergic to light; patients with hyperthyroidism or hypothyroidism; taking glucocorticoids, contraceptives, weight loss drugs and other drugs that affect body weight.

Design outcomes

Secondary

MeasureTime frame
HOMA-IR;Body fat rate;EQ-5D health index scale;TCM main symptom score;Clinical Global Impression scale;HbA1c;Fasting blood glucose;blood fat;blood pressure;

Primary

MeasureTime frame
BMI;the waist;

Countries

China

Contacts

Public ContactZhenjie Liu

Fangcun Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine

zhenjie-liu@163.com+86 13711758166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026